相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pitfalls in genetic counselling for β-thalassemia: an individual with 4 different thalassemia mutations
R. Galanello et al.
CLINICAL GENETICS (2010)
Amelioration of Sardinian β0 thalassemia by genetic modifiers
Renzo Galanello et al.
BLOOD (2009)
The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells
Karin Wahlberg et al.
BLOOD (2009)
BCL11A represses HBG transcription in K562 cells
Zhiyi Chen et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial
Aurelio Maggio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Discovering the genetics underlying foetal haemoglobin production in adults
Swee Lay Thein et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia
Maria Carla Sollaino et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Segmental duplications involving the α-globin gene cluster are causing β-thalassemia intermedia phenotypes in β-thalassemia heterozygous patients
C. L. Harteveld et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
BCL11A is a major HbF quantitative trait locus in three different populations with β-hemoglobinopathies
Amanda E. Sedgewick et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Onset of cardiac iron loading in pediatric patients with thalassemia major
John C. Wood et al.
HAEMATOLOGICA (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
Guillaume Lettre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Once-daily oral deferasirox for the treatment of transfusional iron overload
Renzo Galanello et al.
Expert Review of Clinical Pharmacology (2008)
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
Mark A. Tanner et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2008)
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Jacob Hanna et al.
SCIENCE (2007)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Stephan Menzel et al.
NATURE GENETICS (2007)
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Toshihiko Tanno et al.
NATURE MEDICINE (2007)
Modern treatment of thalassaemia intermedia
Caterina Borgna-Pignatti
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Light and shadows in the iron chelation treatment of haematological diseases
Aurelio Maggio
BRITISH JOURNAL OF HAEMATOLOGY (2007)
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Marius Wernig et al.
NATURE (2007)
Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait focus on chromosome 6q23 influencing fetal hemoglobin levels in adults
Swee Lay Thein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin
Sara Gardenghi et al.
BLOOD (2007)
Liver iron concentrations and urinary hepcidin in β-thalassemia
Raffaella Origa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance
M. A. Tanner et al.
CIRCULATION (2007)
Effects of combined deferiprone and desferrioxamine iron chelating therapy in β-thalassemia major end-stage heart failure -: A case report
Maurizio Porcu et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Molecular analysis of α/β-thalassemia in a southern Chinese population
Bang-Ce Ye et al.
GENETIC TESTING (2007)
A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study
Ravinder Dhallan et al.
LANCET (2007)
Molecular therapies in β-thalassaemia
Lynn Quek et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Identification of nucleated red blood cells in maternal circulation: A second step in screening for fetal aneuploidies and pregnancy complications
A. Mavrou et al.
PRENATAL DIAGNOSIS (2007)
Therapeutic options for patients with severe beta-thalassemia: The need for globin gene therapy
Michel Sadelain et al.
HUMAN GENE THERAPY (2007)
Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera
Orly Weizer-Stern et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction
Betty S. Pace et al.
DEVELOPMENTAL DYNAMICS (2006)
α-Haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of β-thalassaemia
Mei I. Lai et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
C Borgna-Pignatti et al.
BLOOD (2006)
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
DJ Pennell et al.
BLOOD (2006)
Oral chelators deferasirox and defefiprone for transfusional iron overload in thalassen a major: new data, new questions
EJ Neufeld
BLOOD (2006)
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
MD Cappellini et al.
BLOOD (2006)
Correction of the sickle cell mutation in embryonic stem cells
JC Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A role of SMAD4 in iron metabolism through the positive regulation of hepicidin expression
RH Wang et al.
CELL METABOLISM (2005)
Intercentre reproducibility of magnetic resonance T2*measurements of myocardial iron in thalassaemia
MA Westwood et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2005)
Medical progress:: β-thalassemia
D Rund et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Recent advances in fetal nucleic acids in maternal plasma
YMD Lo
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
TG St Pierre et al.
BLOOD (2005)
Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin
C Garner et al.
BLOOD (2004)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
G Puthenveetil et al.
BLOOD (2004)
Somatic deletion of the normal β-globin gene leading to thalassaemia intermedia in heterozygous β-thalassaemic patients
R Galanello et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major
BA Davis et al.
BLOOD (2004)
Hepatocellular carcinoma in the thalassaemia syndromes
C Borgna-Pignatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance
LJ Anderson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia
E Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
AR Cohen et al.
BLOOD (2003)
Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia
M Bradai et al.
BLOOD (2003)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Fetal HLA typing in β thalassaemia:: implications for haemopoietic stem-cell transplantation
MG Orofino et al.
LANCET (2003)
Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with β-thalassaemia major:: application of SQUID biomagnetic liver susceptometry
R Fischer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Rapid screening of multiple β-globin gene mutations by real-time PCR on the LightCycler:: Application to carrier screenig and prenatal diagnosis of thalassemia syndromes
C Vrettou et al.
CLINICAL CHEMISTRY (2003)
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer
S Rivella et al.
BLOOD (2003)
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
F Locatelli et al.
BLOOD (2003)
Proton transverse relaxation rate (R2) images of iron-loaded liver tissuepping local tissue iron concentrations with MRI
PR Clark et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Stern cell transplantation for hemoglobinopathies
J Gaziev et al.
CURRENT OPINION IN PEDIATRICS (2003)
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
LJ Anderson et al.
LANCET (2002)
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
A Ceci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Screening for thalassemia - A model of success
A Cao et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2002)
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation
K Freson et al.
HUMAN MOLECULAR GENETICS (2002)
A novel mechanism for thalassaemia intermedia
C Badens et al.
LANCET (2002)
Evidence of genetic interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin
CP Garner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Cholelithiasis and Gilbert's syndrome in homozygous β-thalassaemia
R Galanello et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
LJ Anderson et al.
EUROPEAN HEART JOURNAL (2001)
Mutations in the general transcription factor TFIIH result in β-thalassaemia in individuals with trichothiodystrophy
V Viprakasit et al.
HUMAN MOLECULAR GENETICS (2001)
Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias
DJ Weatherall
NATURE REVIEWS GENETICS (2001)
Haemochromatosis in patients with β-thalassaemia trait
A Piperno et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Osteoporosis in β-thalassaemia major patients:: analysis of the genetic background
S Perrotta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
